18 January 2017
News and Views
Links and Services
December's issue of the Alimentary Pharmacology & Therapeutics investigates co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab.
There is clear benefit from combination therapy with infliximab and immunosuppressive drugs, but
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors